CANCER GENETICS INC's ticker is CGIXXXXX and the CUSIP is 13739U104. A total of 26 filers reported holding CANCER GENETICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $20,000 | 0.0% | 82,900 | 0.0% | 0.02% | -9.1% |
| Q4 2018 | $20,000 | -91.4% | 82,900 | -63.0% | 0.02% | -90.6% |
| Q3 2018 | $233,000 | +12.0% | 224,170 | -4.3% | 0.23% | -4.1% |
| Q2 2018 | $208,000 | -46.1% | 234,170 | 0.0% | 0.24% | -37.7% |
| Q1 2018 | $386,000 | -10.9% | 234,170 | 0.0% | 0.39% | -2.0% |
| Q4 2017 | $433,000 | -31.2% | 234,170 | +0.4% | 0.40% | -34.8% |
| Q3 2017 | $629,000 | -31.7% | 233,170 | 0.0% | 0.61% | -29.4% |
| Q2 2017 | $921,000 | -3.7% | 233,170 | 0.0% | 0.86% | -8.1% |
| Q1 2017 | $956,000 | +203.5% | 233,170 | 0.0% | 0.94% | +189.2% |
| Q4 2016 | $315,000 | -23.4% | 233,170 | -0.9% | 0.32% | -26.6% |
| Q3 2016 | $411,000 | -11.4% | 235,170 | +0.9% | 0.44% | -20.5% |
| Q2 2016 | $464,000 | – | 233,170 | – | 0.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DOMINI IMPACT INVESTMENTS LLC | 22,203 | $148,000 | 2.90% |
| Millrace Asset Group, Inc. | 187,184 | $1,250,000 | 1.30% |
| Sterneck Capital Management, LLC | 60,650 | $405,000 | 0.24% |
| GRUBER & MCBAINE CAPITAL MANAGEMENT LLC | 83,900 | $560,000 | 0.15% |
| Quality Growth Management, Inc. | 23,500 | $157,000 | 0.12% |
| ARDSLEY ADVISORY PARTNERS LP | 50,000 | $334,000 | 0.05% |
| DIKER MANAGEMENT LLC | 35,015 | $234,000 | 0.05% |
| SSI INVESTMENT MANAGEMENT LLC | 65,043 | $434,000 | 0.04% |
| BANK OF MONTREAL /CAN/ | 616,430 | $4,118,000 | 0.01% |
| Commonwealth Equity Services, Inc | 27,100 | $181,000 | 0.00% |